Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of Gecacitinib in the Peri-Transplant Period for Patients With Myeloid Neoplasms and Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

NCT07883382 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07883382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07883382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of Gecacitinib in the Peri-Transplant Period for Patients With Myeloid Neoplasms and Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
Ruijin Hospital
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
September 30, 2029
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myeloid neoplasms with myelofibrosis